Translation and Validation of the MQOL Self-questionnaire Into French for Assessing Quality of Life in Patients With Meningiomas
Centre Hospitalier St Anne
50 participants
Jun 13, 2025
OBSERVATIONAL
Conditions
Summary
Meningiomas, which account for about 40% of primary central nervous system tumors, have significant psychological and social impacts, even without treatment. Their effect on quality of life is often underestimated and poorly documented. There is one validated questionnaire (MQOL) but it has not yet been translated into French. The project involves two phases: first, translating and linguistically validating the MQOL into French; second, scientifically validating the questionnaire with 50 meningioma patients using established scales (EQ-5D, Karnofsky, FACT-Br) to ensure its reliability and internal consistency.
Eligibility
Inclusion Criteria2
- Patient aged 18 years or older
- Diagnosis of intracranial meningioma confirmed by imaging or surgery
Exclusion Criteria4
- Pregnant or breastfeeding women (Article L1121-5)
- Patients deprived of liberty by judicial or administrative decision, as well as individuals undergoing psychiatric care (Article L1121-6)
- Patients not fluent in French or with poor understanding of the language
- Inability to refuse participation in the study
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The four questionnaires (MQOL, EQ-5D, Karnofsky, and FACT-Br) will be sent to patients online using the secure online platform Redcap.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07044076